Similar articles

• Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.

  Malina L, Chlumský J, Chlumská A. Malina L, et al. Acta Univ Carol Med Monogr. 1974;(59):1-126. Acta Univ Carol Med Monogr. 1974. PMID: 4616623 Review. No abstract available.
• [Clinical findings in porphyria cutanea tarda].

  Heilmann E, Vakilzadeh F. Heilmann E, et al. Fortschr Med. 1977 Mar 10;95(10):659-61. Fortschr Med. 1977. PMID: 844765 German.
• [Experiences with iron elimination therapy in porphyria cutanea tarda].

  Haneke E, Schwartze G. Haneke E, et al. Z Gesamte Inn Med. 1971 Nov 15;26(22):710-6. Z Gesamte Inn Med. 1971. PMID: 5141034 German. No abstract available.
• [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].

  Meister F, Reichen J. Meister F, et al. Schweiz Med Wochenschr. 1986 Mar 15;116(11):341-5. Schweiz Med Wochenschr. 1986. PMID: 3961453 German.
• [Current concepts on the pathogenesis of delayed cutaneous porphyria].

  Enríquez de Salamanca R, Arnalich F. Enríquez de Salamanca R, et al. Rev Clin Esp. 1979 Mar 31;152(6):447-55. Rev Clin Esp. 1979. PMID: 382275 Review. Spanish. No abstract available.